ITGB6-Knockout Suppresses Cholangiocarcinoma Cell Migration and Invasion with Declining PODXL2 Expression
Intrahepatic cholangiocarcinoma (iCCA) is a heterogeneous bile duct cancer with a poor prognosis. Integrin αvβ6 (β6) has been shown to be upregulated in iCCA and is associated with its subclassification and clinicopathological features. In the present study, two ITGB6-knockout HuCCT1 CCA cell lines (ITGB6-ko cells) were established using the clustered regulatory interspaced short palindromic repeats (CRISPR), an associated nuclease 9 (Cas9) system, and single-cell cloning. RNA sequencing analysis, real-time polymerase chain reaction (PCR), and immunofluorescent methods were applied to explore possible downstream factors. ITGB6-ko cells showed significantly decreased expression of integrin β6 on flow cytometric analysis. Both cell lines exhibited significant inhibition of cell migration and invasion, decreased wound-healing capability, decreased colony formation ability, and cell cycle dysregulation. RNA sequencing and real-time PCR analysis revealed a remarkable decrease in podocalyxin-like protein 2 (PODXL2) expression in ITGB6-ko cells. Colocalization of PODXL2 and integrin β6 was also observed. S100 calcium-binding protein P and mucin 1, which are associated with CCA subclassification, were downregulated in ITGB6-ko cells. These results describe the successful generation of ITGB6-ko CCA cell clones with decreased migration and invasion and downregulation of PODXL2, suggesting the utility of integrin β6 as a possible therapeutic target or diagnostic marker candidate.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:22 |
---|---|
Enthalten in: |
International journal of molecular sciences - 22(2021), 12 vom: 11. Juni |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Soejima, Yurie [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 14.07.2021 Date Revised 16.09.2021 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.3390/ijms22126303 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM327550317 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM327550317 | ||
003 | DE-627 | ||
005 | 20231225201030.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/ijms22126303 |2 doi | |
028 | 5 | 2 | |a pubmed24n1091.xml |
035 | |a (DE-627)NLM327550317 | ||
035 | |a (NLM)34208313 | ||
035 | |a (PII)6303 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Soejima, Yurie |e verfasserin |4 aut | |
245 | 1 | 0 | |a ITGB6-Knockout Suppresses Cholangiocarcinoma Cell Migration and Invasion with Declining PODXL2 Expression |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 14.07.2021 | ||
500 | |a Date Revised 16.09.2021 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Intrahepatic cholangiocarcinoma (iCCA) is a heterogeneous bile duct cancer with a poor prognosis. Integrin αvβ6 (β6) has been shown to be upregulated in iCCA and is associated with its subclassification and clinicopathological features. In the present study, two ITGB6-knockout HuCCT1 CCA cell lines (ITGB6-ko cells) were established using the clustered regulatory interspaced short palindromic repeats (CRISPR), an associated nuclease 9 (Cas9) system, and single-cell cloning. RNA sequencing analysis, real-time polymerase chain reaction (PCR), and immunofluorescent methods were applied to explore possible downstream factors. ITGB6-ko cells showed significantly decreased expression of integrin β6 on flow cytometric analysis. Both cell lines exhibited significant inhibition of cell migration and invasion, decreased wound-healing capability, decreased colony formation ability, and cell cycle dysregulation. RNA sequencing and real-time PCR analysis revealed a remarkable decrease in podocalyxin-like protein 2 (PODXL2) expression in ITGB6-ko cells. Colocalization of PODXL2 and integrin β6 was also observed. S100 calcium-binding protein P and mucin 1, which are associated with CCA subclassification, were downregulated in ITGB6-ko cells. These results describe the successful generation of ITGB6-ko CCA cell clones with decreased migration and invasion and downregulation of PODXL2, suggesting the utility of integrin β6 as a possible therapeutic target or diagnostic marker candidate | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a CRISPR/Cas9 | |
650 | 4 | |a ITGB6 | |
650 | 4 | |a PODXL2 | |
650 | 4 | |a RNA-seq | |
650 | 4 | |a cholangiocarcinoma | |
650 | 4 | |a integrin | |
650 | 7 | |a Calcium-Binding Proteins |2 NLM | |
650 | 7 | |a Cell Adhesion Molecules |2 NLM | |
650 | 7 | |a Integrin beta Chains |2 NLM | |
650 | 7 | |a Neoplasm Proteins |2 NLM | |
650 | 7 | |a PODXL2 protein, human |2 NLM | |
650 | 7 | |a RNA, Messenger |2 NLM | |
650 | 7 | |a S100P protein, human |2 NLM | |
650 | 7 | |a Sialoglycoproteins |2 NLM | |
650 | 7 | |a integrin beta6 |2 NLM | |
650 | 7 | |a podocalyxin |2 NLM | |
700 | 1 | |a Takeuchi, Miho |e verfasserin |4 aut | |
700 | 1 | |a Miyamoto, Nao |e verfasserin |4 aut | |
700 | 1 | |a Sawabe, Motoji |e verfasserin |4 aut | |
700 | 1 | |a Fukusato, Toshio |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t International journal of molecular sciences |d 2008 |g 22(2021), 12 vom: 11. Juni |w (DE-627)NLM185552161 |x 1422-0067 |7 nnns |
773 | 1 | 8 | |g volume:22 |g year:2021 |g number:12 |g day:11 |g month:06 |
856 | 4 | 0 | |u http://dx.doi.org/10.3390/ijms22126303 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 22 |j 2021 |e 12 |b 11 |c 06 |